FDA Documentation on Hypercare Antiperspirant Distribution Cessation – Sonar Products Inc./Stratus Pharmaceuticals (2022–2024)

FDA Documentation on Hypercare Antiperspirant Distribution Cessation – Sonar Products Inc./Stratus Pharmaceuticals (2022–2024)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request Contents: For prescription antiperspirant Hypercare (manufactured by Sonar Products Inc. and sold by Stratus Pharmaceuticals): documentation of FDA requesting cessation of distribution and any documentation regarding its status/legal distribution (Request placed in 2022 and fulfilled in 2024)
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details